Group 1 - Company Sanwei Communication announced a partnership to establish a private equity fund with a total investment of 114 million yuan, with the company contributing 25 million yuan, focusing on high-tech industries such as smart manufacturing and new energy [1] - Zijin Mining plans to acquire 100% of Allied Gold Corporation for approximately 280 billion yuan, with core assets including gold mines in Mali and Ivory Coast, and an expected increase in gold production to 25 tons by 2029 [2] - Haike New Source signed a long-term cooperation agreement with BYD Lithium Battery to supply at least 100,000 tons of solvents annually for three years [3] Group 2 - China Aluminum International reported a new contract total of 468.36 billion yuan for 2025, a year-on-year increase of 51.94%, with significant growth in industrial and overseas contracts [4] - Jianxin Co. expects a net loss of 20 to 29 million yuan for 2025, compared to a profit of 19.37 million yuan in the previous year [5] - ST Dongjing anticipates a loss of 40 to 60 million yuan for 2025, an improvement from a loss of 73.45 million yuan in the previous year [6] Group 3 - Zhejiang Haideman plans to raise up to 1.517 billion yuan through a private placement for high-end machine tool projects [7] - Anlu Technology intends to raise up to 1.262 billion yuan for FPGA chip development projects [8][9] - AVIC Chengfei expects a net profit increase of 5.47% to 11.67% for 2025, projecting profits between 3.4 billion and 3.6 billion yuan [10] Group 4 - Hengtong Technology forecasts a net profit increase of 82.95% to 110.05% for 2025, with expected profits between 270 million and 310 million yuan [11] - Qingmu Technology anticipates a net profit increase of 30% to 50% for 2025, projecting profits between 118 million and 136 million yuan [13] - Zhongke Microelectronics expects a loss of 18 to 25 million yuan for 2025, marking a shift from profit to loss [14] Group 5 - Huashan Electric predicts a loss of 42 to 49.2 million yuan for 2025, compared to a loss of 26.77 million yuan in the previous year [15] - Qitian Technology expects a loss of 60 to 95 million yuan for 2025, an improvement from a loss of 214 million yuan in the previous year [16] - Sanyuan Gene announced a plan to reduce its shareholding by up to 2% [17] Group 6 - Zhongxing Junye forecasts a net profit increase of 134.32% to 173.37% for 2025, with expected profits between 300 million and 350 million yuan [18] - Shengshi Technology anticipates a net profit decrease of 50.26% to 64.55% for 2025, projecting profits between 62 million and 87 million yuan [19] - Lante Optical expects a net profit increase of 70.04% to 81.38% for 2025, with projected profits between 375 million and 400 million yuan [20] Group 7 - Dongfang Risen anticipates a loss of 2.3 to 2.9 billion yuan for 2025, compared to a loss of 3.436 billion yuan in the previous year [21] - Wandong Medical announced a change in leadership, electing Wang Jianguo as the new chairman [22] - Longsoft Technology expects a loss of 49 to 60 million yuan for 2025, with projected revenues between 148 million and 164 million yuan [23] Group 8 - Zongyi Co. forecasts a net profit increase of approximately 264.05% for 2025, with expected revenues of around 480 million yuan [24] - Sifang New Materials anticipates a loss of around 300 million yuan for 2025, with projected revenues of about 1 billion yuan [25] - Jiuding New Materials plans to acquire 100% of Jiuding New Energy for 39.51 million yuan [26] Group 9 - Kangyuan Pharmaceutical received approval for clinical trials of a new drug aimed at treating children's ailments [27] - Kaipu Testing announced plans for share reductions by its chairman and vice president [28] - Fengfan Co. intends to acquire 51% of Yanling Jiaye for 382.5 million yuan, with performance commitments for the next three years [29][30] Group 10 - Axin Security received a government subsidy of 6.8 million yuan [31] - Ge Microelectronics announced plans for a share reduction by a major shareholder [32] - ST Yingfit expects a loss of 24 to 31 million yuan for 2025, a reduction from a loss of 40.4 million yuan in the previous year [33] Group 11 - Fujilai forecasts a net profit increase of 282.17% to 296.8% for 2025, with expected profits between 62.7 million and 65.1 million yuan [34] - Huakong Saige anticipates a loss of 97 to 120 million yuan for 2025, a shift from a profit of 17.03 million yuan in the previous year [35] - Landun Optical expects a loss of 70 to 95 million yuan for 2025, compared to a profit of 6.49 million yuan in the previous year [36] Group 12 - ST Zhongji forecasts a loss of 35 to 55 million yuan for 2025, compared to a loss of 231 million yuan in the previous year [37] - Zhongsheng Pharmaceutical expects a profit of 260 to 310 million yuan for 2025, reversing a loss of 299 million yuan in the previous year [38] - Youkeshu reported a net loss of 13.85 million yuan for the first three quarters of 2025 [39] Group 13 - Haosheng Electronics anticipates a net profit decrease of 56.85% to 59.77% for 2025, projecting profits between 69 million and 74 million yuan [40] - Xiangyuan Cultural Tourism plans to withdraw from a low-altitude economic investment fund [41] - Guoen Co. has set a preliminary price range of 34 to 42 HKD for its H-share issuance [42]

| | | 1月26日重要公告精选 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 热点 | 德龙汇能 | 不涉及芯片及相关业务 | | | 东方日升 | 光伏产品未直接向商业航天卫星公司供货 | | 项目投资 | 川环科技 | 拟约11亿元投建川环科技(华东)智造总部基地 | | 合同中标 | 山科智能 | 中标智慧水务平台开发项目 | | 业绩换告 | 均胜电子 | 预计2025年归母净利润约13.5亿元,同比增长40.56% | | 股权转让 | 紫金矿业 | 拟收购AlliedGold Corporation 100%股权 | | 回购 | 吉祥航空 | 已实际回购1.67%公司股份 | | 增减持 | 开普检测 | 董事长姚致清拟减持不超过3%股份 | | 其他 | 浙海德曼 | 拟定增募资不超15.17亿元 | | | 特宝生物 | 拟发行可转债募资不超15.33亿元 片脂磨汇 | 【热点】 浙文互联(600986.SH)：旗下"派智"数字人业务产生的收入和利润占公司营业收入和净利润的比例均不到 1%，占比较小 东方日升(300118.SZ)：光伏产品未直接向 ...

Core Viewpoint - Zhejiang Haideman Intelligent Equipment Co., Ltd. plans to issue shares to no more than 35 specific investors, which is expected to dilute the immediate returns for existing shareholders due to the gradual release of anticipated project returns from the raised funds [1][6]. Financial Impact Analysis - The company assumes that the macroeconomic environment, industry policies, and operational conditions remain unchanged for the financial impact assessment of the share issuance [2]. - The total amount to be raised from the issuance is estimated at 1,517 million yuan, excluding issuance costs [2]. - Before the issuance, the total share capital is 111,279,729 shares, and after issuing up to 33,383,918 shares, the total will be 144,663,647 shares [3]. - The company reported a net profit of 30.89 million yuan for the first three quarters of 2025, with a projected annual net profit for 2025 and 2026 based on various scenarios [3][4]. Necessity and Reasonableness of the Issuance - The fundraising projects have been rigorously evaluated and are deemed necessary to enhance the company's core competitiveness and sustainable development capabilities [7]. - The funds will be allocated to projects related to high-end composite machine tools and precision machine tool R&D, as well as to supplement working capital [8]. Relationship with Existing Business - The company specializes in the R&D, design, production, and sales of CNC machine tools, focusing on high-precision technology [8]. - The projects funded by the issuance aim to expand production capacity and enhance product offerings in response to market demands [8]. Measures to Mitigate Dilution of Immediate Returns - The company plans to enhance product R&D and market expansion, improve operational efficiency, and ensure proper management of raised funds to mitigate the dilution of immediate returns [14]. - Specific measures include increasing R&D efforts, optimizing daily operations, and maintaining a stable profit distribution system [14][15][16]. Commitments from Company Executives - Company executives have committed to fulfilling the measures to compensate for the dilution of immediate returns, ensuring no unfair benefits are provided to other parties [19][21]. - The commitments include adherence to regulations and ensuring that the interests of all shareholders are protected [19][21].

智通财经APP讯，浙海德曼(688577.SH)发布公告，公司拟向特定对象发行股票，募集资金总额不超过 15.17亿元(含本数)，募集资金在扣除相关发行费用后的募集资金净额将全部用于：高端复合化机床产业 化项目、高端精密机床与机器人硬件智造研发项目、补充流动资金。 ...

Group 1 - Evert plans to acquire equity in Shengpu Co., with stock suspension starting January 27, 2026, expected to last no more than 10 trading days [5] - Haike New Source signed a long-term cooperation agreement with BYD Lithium Battery to supply at least 100,000 tons of electrolyte solvent annually for three years [5] - Sanxiang Bio has developed a CE-certified Nipah virus nucleic acid testing kit and a domestic research version, responding to the Nipah virus outbreak in India [9][10] Group 2 - Sangfor Health expects a Q4 net profit of approximately 2.5 billion yuan, a 1097% increase from the previous quarter, driven by a significant payment from Pfizer for the 707 project [2] - Puran Co. anticipates a Q4 net profit of about 1.46 billion yuan, a 696% increase from Q3, despite an annual decrease of approximately 29.89% [3][4] - Chip Source Micro expects a net profit of 52 million to 76 million yuan for 2025, a decrease of 62.53% to 74.36% year-on-year due to increased costs and reduced other income [6] Group 3 - Maide Medical forecasts a net profit of approximately 66.5 million yuan for 2025, marking a turnaround from losses in the previous year [7] - Ruixin Micro expects a net profit of 1.023 billion to 1.103 billion yuan for 2025, representing a growth of 71.97% to 85.42% year-on-year [8] - Qingda Environmental anticipates a net profit of 165 million to 190 million yuan for 2025, an increase of 77.47% to 104.36% year-on-year [10] Group 4 - Jiangxun Technology expects a net profit increase of approximately 86.44% for 2025, reaching around 156 million yuan [11] - Micron Bio anticipates a net profit of approximately 53.5 million yuan for 2025, achieving profitability after previous losses [11] - Blue Special Optics forecasts a net profit of 375 million to 400 million yuan for 2025, a growth of 70.04% to 81.38% year-on-year [13]

Core Viewpoint - Zhejiang Haideman plans to raise up to 1.517 billion yuan through a private placement of shares, with the funds allocated for high-end composite machine tool industrialization, high-precision machine tool and robot hardware R&D, and working capital supplementation [1] Group 1: Company Overview - Zhejiang Haideman specializes in the R&D, design, production, and sales of CNC lathes, focusing on breakthroughs in high-precision CNC lathes [1] - The company offers four main product categories: high-end CNC lathes, automated production lines, parallel composite processing centers, and popular CNC lathes, primarily used in automotive manufacturing, engineering machinery, general equipment, aerospace, and military industries [1] Group 2: Market Demand and Expansion - The domestic production of high-end CNC machine tools has become a necessary trend due to overseas technology blockades and trade barriers, with national policies supporting the industry's development [2] - The increasing demand for CNC machine tools and the need for core processing equipment updates in downstream applications have led to a situation where the existing production capacity is insufficient to meet the growing customer orders [2] - The fundraising project will enhance production capacity for T-series CNC lathes and automated production lines, allowing the company to seize market opportunities in automotive manufacturing, engineering machinery, general equipment, robotics, aerospace, military, and semiconductor industries [2] Group 3: Technological Advancements - The implementation of the fundraising project will enable large-scale production of horizontal machining centers, five-axis linkage machining centers, and five-axis turning-milling composite machining centers, providing advanced equipment with composite processing capabilities [3] - The high technical added value of high-end CNC machine tools will enhance the company's profitability and support the completion of technological upgrades, improving the product lineup and laying a solid technical foundation for long-term development [3] - The company aims to address challenges in the robotics sector by establishing specialized R&D facilities, forming R&D teams, and acquiring equipment to develop dedicated processing equipment and core components for intelligent manufacturing and automated assembly [3]

MACD金叉信号形成，这些股涨势不错！ 格隆汇1月26日丨浙海德曼(688577.SH)公布2026年度向特定对象发行A股股票预案，本次发行拟募集资 金总额不超过15.17亿元（含本数），募集资金在扣除相关发行费用后的募集资金净额将全部用于以下 项目：高端复合化机床产业化项目、高端精密机床与机器人硬件智造研发项目及补充流动资金。 ...

证券代码：688577 证券简称：浙海德曼 浙江海德曼智能装备股份有限公司 关于 2026 年度向特定对象发行股票方案的 论证分析报告 二〇二六年一月 浙江海德曼智能装备股份有限公司（以下简称"浙海德曼"、"发行人"或"公 司"）是上海证券交易所科创板上市的公司。为满足公司业务发展的资金需求， 增强公司的资本实力和盈利能力，根据《中华人民共和国公司法》《中华人民共 和国证券法》和《上市公司证券发行注册管理办法》（以下简称"《注册管理办法》"） 等有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定，公司编 制了 2026 年度向特定对象发行股票方案的论证分析报告。 本论证分析报告中如无特别说明，相关用语具有与《浙江海德曼智能装备股 份有限公司 2026 年度向特定对象发行股票预案》中相同的含义。 一、本次向特定对象发行股票的背景和目的 （一）本次发行的背景 机床，是将金属毛坯加工成零部件的机器，被誉为"工业母机"，是工业品 生产不可或缺的基础设备。机床的技术水平直接决定了汽车制造、工程机械、通 用设备、机器人、航空航天、国防军工、半导体设备等战略领域的发展高度，是 衡量我国现代化制造业水平的重要标志， ...

证券代码：688577 证券简称：浙海德曼 浙江海德曼智能装备股份有限公司 2026 年度向特定对象发行股票预案 二〇二六年一月 浙江海德曼智能装备股份有限公司 2026 年度向特定对象发行股票预案 公司声明 1、本公司及董事会全体成员保证本预案内容真实、准确、完整，不存在虚 假记载、误导性陈述或重大遗漏，按照诚信原则履行承诺，并承担相应的法律责 任。 2、本预案按照《上市公司证券发行注册管理办法》等法规及规范性文件的 要求编制。 3、本次向特定对象发行股票完成后，公司经营与收益的变化由公司自行负 责；因本次向特定对象发行股票引致的投资风险，由投资者自行负责。 4、本预案是公司董事会对本次向特定对象发行股票的说明，任何与之不一 致的声明均属不实陈述。 5、投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或 其他专业顾问。 6、本预案所述事项并不代表审批机构对于本次向特定对象发行股票相关事 项的实质性判断、确认、批准。 本预案所述本次向特定对象发行股票相关事项的生效和完成尚待取得有关 审批机关的批准及同意注册。 2 浙江海德曼智能装备股份有限公司 2026 年度向特定对象发行股票预案 重大事项提示 ...

证券代码：688577 证券简称：浙海德曼 公告编号：2026-001 敬请广大投资者注意投资风险。 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 预案等相关文件的披露不代表中国证券监督管理委员会、上海证券交易所对公司 本次向特定对象发行股票事项进行了实质性判断、批准或核准，预案所述公司本次向 特定对象发行股票事项尚待审批机关的批准与核准。 浙江海德曼智能装备股份有限公司（以下简称"公司"）于 2026 年 1 月 26 日召 开第四届董事会第九次会议，审议通过了关于公司 2026 年度向特定对象发行 A 股股 票（以下简称"本次发行"）等相关议案。 《浙江海德曼智能装备股份有限公司 2026 年度向特定对象发行股票预案》等相 关文件已于同日在上海证券交易所指定信息披露平台及信息披露媒体上进行披露，敬 请投资者查阅。 浙江海德曼智能装备股份有限公司 关于 2026 年度向特定对象发行股票预案披露的提示性公告 浙江海德曼智能装备股份有限公司董事会 2026年1月27日 ...